Please Note: This trial is no longer enrolling new participants
A First in Human, Phase 1, Open-Label Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 4A10 Monotherapy In Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
| Protocol No. | PHO-ALLTERUM-ALT-101 | Scope | National |
|---|---|---|---|
| Principal Investigator | Sandeep Batra | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase I |
